Physician Photo

Flavia V. Castelino, MD

  • Phone: 617-726-7938
Departments
Rheumatology
Department of Medicine
Clinical Interests
Scleroderma/Systemic sclerosis
Connective tissue associated interstitial lung disease
Raynaud's phenomenon
Rheumatoid arthritis
Dermatomyositis
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, SUNY at Syracuse (Upstate)
Residency, Northwestern Memorial Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Rheumatology, American Board of Internal Medicine
Gender
Female
Patient Gateway
Yes, learn more
Patient Age Group
Adult
Accepting New Patients
Yes

Biography

Dr. Flavia Castelino is an Assistant Professor of Medicine at Harvard Medical School and a board-certified physician in the Division of Rheumatology at Massachusetts General Hospital. Dr. Castelino specializes in the treatment of scleroderma and connective tissue disease-associated lung disease.

Her research focuses on the role of lipid mediators in scleroderma fibrosis. Dr. Castelino is a member of the Early Career Investigator Subcommittee of the American College of Rheumatology and the Scleroderma Clinical Trials Consortium. She acts as a reviewer for multiple rheumatology journals including Arthritis and Rheumatology, Arthritis Care and Research and Arthritis Research and Therapy.  She is the recipient of numerous awards including the American College of Rheumatology Physician-Scientist Development Award and the Scleroderma Foundation Walter A. Coyle Memorial Research Award. Recently, she was awarded a National Institute of Health research grant to study the role of a lipid mediator, lysophosphatidic acid in scleroderma fibrosis. 

Publications

View my most recent publications at PubMed

Selected Publications:

Castelino FV
, Varga J. Current Status of Systemic Sclerosis Biomarkers. Expert Rev Clin Immunol, 2013 Nov; 9 (11):1077-90.   

Castelino FV
.  Lipids and Eicosanoids in Fibrosis: Emerging Targets for Therapy.  Curr Op Rheum 2012; 24 (6): 649-655.

Castelino FV
, Goldberg H, Dellaripa PF. The Impact of Rheumatologic Evaluation in the Management of Patients with Interstitial Lung Disease. Rheumatology 2011 Mar;50(3):489-93.

Castelino FV
, Seiders J, Bain G, Brooks SF, King C, Swaney J, Lorrain D, Chun J, Luster AD, Tager AM. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis and Rheumatism, 2011. May; 63(5):1405-15.

Rheumatology Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-7938